CERAD-neuropsychological battery in screening mild Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 125, Issue 1, 2012, Pages 16-23

  Sotaniemi, M ^a,b   Pulliainen, V ^c   Hokkanen, L ^a   Pirttila T ^d,e   Hallikainen, I ^e   Soininen, H ^d,e   Hanninen T ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Kellokoski Hospital   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; CERAD nb; Cut off point; Dementia; Memory

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER DISEASE NEUROPSYCHOLOGICAL BATTERY; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PSYCHOLOGIC TEST; SENSITIVITY AND SPECIFICITY; VERBAL MEMORY; WORD LIST RECALL; WORD RECOGNITION;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COGNITION; FEMALE; HUMANS; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84155174827     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01459.x     Document Type: Article

References (46)

1. Ashford JW. Screening for memory disorders, dementia and Alzheimer's disease. Aging Health 2008;4:399-432.
2. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46.
3. Folstein MF, Folstein SE, Mchugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
4. Tierney MC, Szalai JP, Dunn E, Geslani D, Mcdowell I. Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination. Arch Fam Med 2000;9:527-32.
5. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-52.
6. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278-81.
7. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992;49:448-52.
8. Schultz RR. Memory with emotional content, brain amygdala and Alzheimer's disease. Acta Neurol Scand 2009;120:101-10.
9. Twamley EW, Ropacki SA, Bondi MW. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006;12:707-35.
10. Chen P, Ratcliff G, Belle SH, Cauley JA, Dekosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000;55:1847-53.
11. Wiig EH, Annas P, Basun H et al. The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease. Acta Neurol Scand 2010;121:186-93.
12. Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999;53:670-8.
13. Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc 2002;8:566-83.
14. Collerton D, Burn D, Mckeith I, O'brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord 2003;16:229.
15. Fillenbaum GG, Van Belle G, Morris JC et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement 2008;4:96-109.
16. Aebi C. Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi-Center Studie [dissertation]. University of Basel: Faculty of Humanities, 2002.
17. Pulliainen V, Hokkanen L, Salo J, Hänninen T. CERAD-kognitiivinen tehtäväsarja. Käsikirja. [Manual of the Finnish version of the CERAD]. Kuopio: Suomen Alzheimertutkimusseura ry, 1999.
18. Hänninen T, Pulliainen V, Salo J et al. Kognitiiviset testit muistihäiriöiden ja alkavan dementian varhaisdiagnostiikassa: CERAD-tehtäväsarja. [Cognitive tests in diagnosing memory disorders and early dementia: CERAD-nb]. Suom Laakaril 1999;54:1967-75.
19. Welsh KA, Butters N, Mohs RC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994;44:609-14.
20. Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand 2005;111:172-9.
21. Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002;106:148-54.
22. Tervo S, Kivipelto M, Hänninen T et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196-203.
23. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-4.
24. Välimäki TH, Vehviläinen-Julkunen KM, Pietilä AM, Pirttilä TA. Caregiver depression is associated with a low sense of coherence and health-related quality of life. Aging Ment Health 2009;13:799-807.
25. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
26. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998;64:588-94.
27. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
28. Laine M, Koivuselkä-Sallinen P, Hänninen R, Niemi J. Bostonin nimentätesti. [The Finnish version of Boston naming test]. Helsinki: Psykologien Kustannus, 1997.
29. Dubois B, Picard G, Sarazin M. Early detection of Alzheimer's disease: new diagnostic criteria. Dialogues Clin Neurosci 2009;11:135-9.
30. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001;59:532-6.
31. Sarazin M, Berr C, De Rotrou J et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007;69:1859-67.
32. Dudas RB. Episodic and semantic memory in mild cognitive impairment. Neuropsychologia 2005;43:1266-76.
33. Adlam AL. Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease. Cortex 2006;42:675-84.
34. Balthazar MLF. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption? Neuropsychology 2008;22:703.
35. Pinto E, Peters R. Literature review of the Clock Drawing Test as a tool for cognitive screening. Dement Geriatr Cogn Disord 2009;27:201-13.
36. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005;19:520-31.
37. Graham NL. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75:61-71.
38. Fukui T, Lee E, Kitamura M et al. Visuospatial dysfunction may be a key in the differentiation between Alzheimer's disease and subcortical cognitive impairment in moderate to severe stages. Dement Geriatr Cogn Disord 2009;28:288-94.
39. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997;62:243-52.
40. Kraybill ML. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 2005;64:2069.
41. Diehl J, Monsch AU, Aebi C et al. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis. J Geriatr Psychiatry Neurol 2005;18:39-44.
42. Andel R, Mccleary CA, Murdock GA, Fiske A, Wilcox RR, Gatz M. Performance on the CERAD Word List Memory task: a comparison of university-based and community-based groups. Int J Geriatr Psychiatry 2003;18:733-9.
43. Fillenbaum GG, Heyman A, Huber MS, Ganguli M, Unverzagt FW. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery. J Int Neuropsychol Soc 2001;7:502-9.
44. Karrasch M, Laine M. Age, education and test performance on the Finnish CERAD. Acta Neurol Scand 2003;108:97-101.
45. Beeri MS, Schmeidler J, Sano M et al. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology 2006;67: 1006-10.
46. Pulliainen V, Hänninen T, Hokkanen L et al. Muistihäiriöiden seulonta -suomalaiset normit CERAD -tehtäväsarjalle [Norms for use of the CERAD test battery in Finland]. Suom Laakaril 2007;12:1235-41.